{
    "organizations": [],
    "uuid": "dbfff55e488fd994109dd838a34055770140f239",
    "author": "",
    "url": "https://www.reuters.com/article/brief-repros-announces-negative-opinion/brief-repros-announces-negative-opinion-from-the-ema-for-enclomiphene-idUSFWN1PL18Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Repros Announces Negative Opinion From The EMA For Enclomiphene",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 26, 2018 / 11:28 PM / in 3 hours BRIEF-Repros Announces Negative Opinion From The EMA For Enclomiphene Reuters Staff \nJan 26 (Reuters) - Repros Therapeutics Inc: \n* REPROS ANNOUNCES NEGATIVE OPINION FROM THE EMA FOR ENCLOMIPHENE \n* CHMP HAS FORMALLY ISSUED A NEGATIVE OPINION FOR CENTRALIZED MAA FOR ENCLOMIPHENE FOR TREATMENT OF SECONDARY HYPOGONADISM Source text for Eikon: Further company coverage:",
    "published": "2018-01-27T01:28:00.000+02:00",
    "crawled": "2018-01-27T01:44:05.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "hour",
        "announces",
        "negative",
        "opinion",
        "ema",
        "enclomiphene",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "repros",
        "therapeutic",
        "inc",
        "repros",
        "announces",
        "negative",
        "opinion",
        "ema",
        "enclomiphene",
        "chmp",
        "formally",
        "issued",
        "negative",
        "opinion",
        "centralized",
        "maa",
        "enclomiphene",
        "treatment",
        "secondary",
        "hypogonadism",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}